What emergency drug is administered to stabilize ventricular fibrillation in the operating room?

What emergency drug is administered to stabilize ventricular fibrillation in the operating room?

• A. Anectine
• B. Isoproterenol
• C. Vasopressin
• D. Nitroglycerine

Answer: (B)

The drug that is commonly administered to stabilize ventricular fibrillation in the operating room is isoproterenol. Isoproterenol is a potent beta-adrenergic agonist that can help facilitate the heart's electrical activity by increasing heart rate and myocardial contractility. It can be especially useful during certain cardiac dysrhythmias, including ventricular fibrillation, as it works to improve perfusion and can help restore a more stable rhythm. The other options, although they have their own uses, do not directly target the stabilization of ventricular fibrillation in the same effective manner. For instance, Anectine is a neuromuscular blocker used mainly for intubation and does not have an effect on ventricular rhythm. Vasopressin, while useful in cardiac arrest situations, is more effective in other types of arrest and does not specifically address ventricular fibrillation as isoproterenol does. Nitroglycerine is primarily used for its vasodilatory effects in angina and hypertension but does not have a role in stabilizing ventricular fibrillation. Thus, the use of isoproterenol in this scenario is valid, as it enhances cardiac output and promotes the restoration of a normal rhythm during an emergency situation involving ventricular fibrillation.

The drug that is commonly administered to stabilize ventricular fibrillation in the operating room is isoproterenol. Isoproterenol is a potent beta-adrenergic agonist that can help facilitate the heart's electrical activity by increasing heart rate and myocardial contractility. It can be especially useful during certain cardiac dysrhythmias, including ventricular fibrillation, as it works to improve perfusion and can help restore a more stable rhythm.

The other options, although they have their own uses, do not directly target the stabilization of ventricular fibrillation in the same effective manner. For instance, Anectine is a neuromuscular blocker used mainly for intubation and does not have an effect on ventricular rhythm. Vasopressin, while useful in cardiac arrest situations, is more effective in other types of arrest and does not specifically address ventricular fibrillation as isoproterenol does. Nitroglycerine is primarily used for its vasodilatory effects in angina and hypertension but does not have a role in stabilizing ventricular fibrillation.

Thus, the use of isoproterenol in this scenario is valid, as it enhances cardiac output and promotes the restoration of a normal rhythm during an emergency situation involving ventricular fibrillation.